Tonix Pharmaceuticals enrolled first participant in PRECISION Study for COVID-19 vaccines and therapeutics
On Oct. 15, 2020, Tonix Pharmaceuticals announced that the first participant was enrolled in the observational PRECISION study…
-
-
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
-
FDA approved first treatment for Ebola virus
On Oct. 14, 2020, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceutical’s Inmazeb (atoltivimab, maftivimab, and…
-
US DOD expanded collaboration with AstraZeneca to develop and manufacture an investigational mab to prevent COVID-19
On Oct. 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD)…
-
Thermo Fisher announced plans to expand sterile filling capacity for therapies and vaccines with new facility in Singapore
On Oct. 14, 2020, Thermo Fisher Scientific announced plans to develop two new sterile filling lines in Singapore…
-
America’s Top Young Scientist of 2020: 14-year-old researched spike protein of SARS-CoV-2 virus
On Oct. 14, 2020, 3M and Discovery Education announced they had named 14-year-old Anika Chebrolu from Frisco, Texas,…
-
Tevogen Bio submitted IND for T cell treatment in COVID-19
On Oct. 14, 2020, Tevogen Bio announced that its Investigational New Drug (IND) application to develop a COVID-19…
-
Regeneron’s antibody cocktail REGN-EB3 (Inmazeb) first FDA-approved treatment for Ebola (Zaire Ebolavirus)
On Oct. 14, 2020, Regeneron announced that the U.S. Food and Drug Administration (FDA) had approved Inmazeb (atoltivimab,…
-
Roche launched laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
On Oct. 13, 2020, Roche announced that it intended to launch a high-volume SARS-CoV-2 Antigen test as an…
-
NIH study to identify promising COVID-19 treatments for larger clinical trials
On Oct. 13, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), launched a study designed to…
-
RedHill Biopharma announced partnerships to expand manufacturing for COVID-19 therapeutic candidate opaganib
On Oct. 13, 2020, RedHill Biopharma announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to…
-
Mosquitoes’ taste for blood traced to four types of neurons
On Oct. 12, 2020, Howard Hughes Medical Institute Investigator Leslie Vosshall’s team at The Rockefeller University and colleagues…
-
Racial differences in Alzheimer’s research focus of $15 million grant
On Oct. 12, 2020, the Washington University School of Medicine in St. Louis announced a $14.6 million grant…
-
The CDC released a new national antibiotic resistance plan
On Oct. 9, 2020, the U.S. Centers for Disease Control and Prevention (CDC) released a new National Action…
-
Rigel announced first patients enrolled in trial of fostamatinib in hospitalized COVID-19 patients in collaboration with Inova
On Oct. 9, 2020, Rigel Pharma announced enrollment of the first patients in a multicenter, Phase 2 trial…
-
NIH launched the Serological Sciences Network for COVID-19, announced grant and contract awardees
On Oct. 8, 2020, the National Cancer Institute (NCI) launched the Serological Sciences Network for COVID-19 (SeroNet), an…
-
NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 began
On Oct. 8, 2020, a clinical trial to test the safety, tolerability and efficacy of a combination treatment…
-
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine
Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review published
On Oct. 8, 2020, the relation between COVID-19 and Guillain-Barre syndrome (GBS) in adults: a systematic review was…
-
Gilead Sciences signed joint procurement agreement with European Commission for Veklury (remdesivir)
On Oct. 8, 2020, Gilead Sciences and the European Commission signed a joint procurement agreement (JPA) that enabled…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
-
Lilly announced supply of potential COVID-19 antibody therapy for low- and middle-income countries
On Oct. 8, 2020, Eli Lilly and Incyte shared sharing additional data showing baricitinib in combination with remdesivir…
-
Caladrius Biosciences opened study of CLBS119 to repair COVID-19-induced lung damage
On Oct. 8, 2020, Caladrius Biosciences announced that it had opened its proof-of-concept study of CLBS119 as a…
-
RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review
On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…
-
Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection
On Oct. 7, 2020, Sorrento Therapeutics announced that it had discovered a small molecule termed Salicyn-30 that demonstrated…
-
Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19
On Oct. 7, 2020, Mateon Therapeutics announced the first patient enrolled this week in its Phase IV study…
-
Lilly updated progress of SARS-CoV-2 neutralizing antibody programs
On Oct. 7, 2020, Eli Lilly announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim…
-
Chemicals similar to those found in cannabis can inhibit bacterial virulence
On Oct. 7, 2020, UT Southwestern scientists showed that endocannabinoids, signaling molecules produced in the body that share…
-
Biotechnology | Chemistry | CRISPR | Genomics | Oncology | Therapeutics
Nobel Prize in Chemistry for 2020 awarded to Emmanuelle Charpentier and Jennifer A Doudna “for the development of a method for genome editing”
On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Drs. Emmanuelle Charpentier and Jennifer…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | FDA | Infectious Disease | Therapeutics
Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performance
On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…
-
NIH RADx initiative advanced six new COVID-19 testing technologies
On Oct. 6, 2020, the National Institutes of Health (NIH), working in collaboration with the Biomedical Advanced Research…
